October 08, 2026 08:54 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
‘Bold and inventive’: Canadian poet Anne Carson wins 2026 Nobel Prize in Literature | ‘Attempt to destabilise world’s largest democracy’: 42 retired judges rally behind Gyanesh Kumar over ‘vote chori’ row | ‘Vote chor, gaddi chod’: Dhruv Rathee, Prakash Raj join Bengaluru protest against Gyanesh Kumar | India condemns Houthi attacks on Saudi airports, calls targeting of civilian infrastructure unacceptable | Dalal Street bloodbath: Investors lose Rs. 8 lakh crore as Sensex crashes over 1,000 points | Amazon layoffs hit India, US and UK: Fresh job cuts rock e-commerce giant amid festive shopping season | Bollywood mourns Nana Patekar: Anupam Kher, Akshay Kumar, Jr NTR, Suniel Shetty pay emotional tributes | ‘He was never wavering while expressing his opinions’: PM Modi mourns Nana Patekar | Nana Patekar dies at 75: Veteran actor suffers cardiac arrest at Goa home | RBI shocks borrowers with first repo rate hike since 2023; rates raised to 5.50%
IndiaFightsCorona
Image Credit: UNI

'Maintain strict vigil': Centre directs 4 states amid rise in Covid-19 cases

| @indiablooms | Jan 08, 2021, at 02:07 am

New Delhi/IBNS: Union Health Secretary Rajesh Bhushan has written to four states-Maharashtra, Kerala, Chhattisgarh and West Bengal-urging them to maintain a 'strict vigil' in curbing the spike in Covid-19 cases.

These states have reported an upsurge in the number of daily news cases in recent days and comprise 59% of the total active cases in the country.

In the Health Secretary's letter, the states have been advised to maintain a ‘strict vigil’ and to take steps to keep a check on the rising cases, especially in view of the new strain of the virus being observed in certain countries which have also been reported in a few states in India.

Bhushan has drawn the attention of the states to the low and declining testing rates, noting that any laxity at this crucial junction may "squander the results of our collective actions in containing the transmission".

They have been advised to analyse the surge at the district and sub-district levels to understand the reasons for this rise and plan adequate measures proactively to curb the same.

Aggressively implementation of the ‘Test-Track-Treat” strategy adopted by the country has been strongly advised now more than ever by the Union Health Secretary.

The health authorities in the states have also been advised to proactively promote the wearing of masks and other COVID appropriate behaviours even while the vaccination drive is about to begin.

"It is important to ensure that there is no complacency in the collective efforts in containment and management of Covid-19," the Health Secretary has strongly reiterated.

The states have been assured of all necessary support of the Health Ministry required to manage the pandemic.

The total COVID-19 cases in Kerala are 7,90,882 which form 7.61 pct of the total cases.

Meanwhile, in Maharashtra, the total cases stand at 19,54,553 accounting for 18.80% of the national figure.

A total of 18,52,759 patients have recovered in the state resulting in the recovery rate of 94.79 per cent.

Chhattisgarh has registered 2,85,586 total cases (with per cent share in total being 2.75%) and 2,73,030 total number of recoveries with a recovery rate of 95.60 per cent.

The eastern state of West Bengal has reported 5,57,252 total cases contributing 5.36 pct while the recovery rate stands at 96.64 pct. It has 8,868 active cases comprising 3.89 per cent of the national figure.

Worryingly, India now has over 70 cases of the new mutant strain of coronavirus, which is considered to be more infectious.

Overall India has 2,29 lakh active cases and has reported over 1.5 lakh deaths since the pandemic began in December 2019.

The Centre on Tuesday informed that Covid-19 vaccines will be ready for rollout in 10 days from the emergency use authorisation date based on feedback from the dry run.

Two Covid-19 vaccine candidates-Hyderabad-based Bharat Biotech's Covaxin and the Serum Institute of India's Covishield-on Sunday received the approval of the Drugs Controller General of India (DCGI) for emergency use in India.

 

 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.